AZN

AZN Biotechnology CGEN GILD GILD:CA Terry Chrisomalis Uncategorized

Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement

Mar 2, 2026

AZN BBIO BIIB Biotechnology Bret Jensen GSK IONS NTLA NVS PFE REGN Uncategorized

Ionis Pharmaceuticals: Digesting Recent Events

Feb 27, 2026

AZN Biotechnology Busted IPO Forum MRK NVS TECX TENX Uncategorized

Tenax Therapeutics: Some Future Potential

Feb 26, 2026

ABBV AZN Biotechnology RHHBF RHHBY Uncategorized

AbbVie wins FDA nod for Venclexta-acalabrutinib combo in first-line chronic lymphocytic leukemia

Feb 20, 2026

AZN Biotechnology BNTX GSK MRK MRNA NVAX PFE SNY Uncategorized

Changes to U.S. vaccine policy under RFK Jr. challenged in court

Feb 14, 2026

AZN Biotechnology BNTX GSK MRK MRNA NVAX PFE SNY SNYNF Uncategorized

HHS secretary RFK Jr. adds two new members to CDC vaccine panel

Jan 13, 2026

abbvie-secures-tariff-relief-in-drug-pricing-deal,-pledges-$100b-investment

ABBV AMGN AZN Biotechnology BMY GILD LLY MRK NVO PFE Uncategorized

AbbVie secures tariff relief in drug pricing deal, pledges $100B investment

Jan 13, 2026

Comments (22) vzphotos/iStock Editorial via Getty Images AbbVie (ABBV) has reached a three-year deal with...

AZN Biotechnology BNTX GCVRZ GSK MRK MRNA NVAX PFE SNY SNYNF Uncategorized

CDC updates childhood vaccine schedule to recommend fewer shots

Jan 5, 2026

AZN Biotechnology GILD MRK RPTX Uncategorized

Gilead to buy Repare Thera’s cancer candidate for up to $30M

Dec 24, 2025

abbvie,-bristol-myers,-merck-among-latest-to-announce-us.-drug-pricing-deals:-reuters

ABBV AZN Biotechnology BMY GILD LLY MRK NVO NVS PFE RHHBY Uncategorized

AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters

Dec 19, 2025

Comments (11) LIgorko/iStock via Getty Images Leading drugmakers, including AbbVie (ABBV), Bristol Myers Squibb (BMY),...

Next Page »